tiprankstipranks
Corbus Pharmaceuticals (CRBP)
NASDAQ:CRBP
Holding CRBP?
Track your performance easily

Corbus Pharmaceuticals (CRBP) Income Statement

2,321 Followers

Corbus Pharmaceuticals Income Statement

Last quarter (Q3 2024), Corbus Pharmaceuticals's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Corbus Pharmaceuticals's net income was $-13.78M. See Corbus Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
---$ 881.71K$ 3.94M$ 36.14M
Cost of Revenue
------
Gross Profit
---$ 881.71K$ 3.94M$ 36.14M
Operating Expense
$ 46.22M$ 45.08M$ 34.84M$ 56.87M$ 126.75M$ 113.25M
Operating Income
$ -46.22M$ -45.08M$ -39.84M$ -55.99M$ -122.81M$ -77.10M
Net Non Operating Interest Income Expense
$ 558.98K$ -2.92M$ -2.13M$ -1.83M$ -1.03M$ 5.81M
Other Income Expense
$ -1.78M$ 3.40M$ -5.38M$ -12.50M$ -13.02M$ -4.58M
Pretax Income
$ -38.23M$ -44.60M$ -42.35M$ -45.70M$ -111.27M$ -71.45M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -38.76M$ -44.60M$ -42.35M$ -45.64M$ -111.27M$ -71.45M
Basic EPS
$ -4.63$ -10.31$ -10.15$ -11.10$ -42.60-
Diluted EPS
$ -4.63$ -10.31$ -10.15$ -11.10$ -42.60$ -33.60
Basic Average Shares
$ 35.81M$ 4.33M$ 4.17M$ 4.10M$ 2.60M$ 2.13M
Diluted Average Shares
$ 35.81M$ 4.33M$ 4.17M$ 4.10M$ 2.60M$ 2.13M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 46.22M$ 45.08M$ 34.84M$ 56.87M$ 126.75M$ 113.25M
Net Income From Continuing And Discontinued Operation
$ -38.70M$ -44.60M$ -42.35M$ -45.64M$ -111.27M$ -71.45M
Normalized Income
$ -36.12M$ -35.14M-$ -36.11M--
Interest Expense
------
EBIT
$ -42.98M$ -45.08M$ -34.84M$ -55.99M$ -122.81M$ -72.68M
EBITDA
$ -41.99M$ -44.44M$ -34.07M$ -54.35M$ -121.12M$ -71.45M
Currency in USD

Corbus Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis